372 related articles for article (PubMed ID: 33266470)
1. Serum and Glucocorticoid-Inducible Kinase 1 (SGK1) in NSCLC Therapy.
Guerriero I; Monaco G; Coppola V; Orlacchio A
Pharmaceuticals (Basel); 2020 Nov; 13(11):. PubMed ID: 33266470
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of SGK1 potentiates the anticancer activity of PI3K inhibitor in NSCLC cells through modulation of mTORC1, p‑ERK and β‑catenin signaling.
Kale R; Samant C; Bokare A; Verma M; Nandakumar K; Bhonde M
Biomed Rep; 2023 Dec; 19(6):94. PubMed ID: 37901878
[TBL] [Abstract][Full Text] [Related]
3. The prospect of serum and glucocorticoid-inducible kinase 1 (SGK1) in cancer therapy: a rising star.
Zhu R; Yang G; Cao Z; Shen K; Zheng L; Xiao J; You L; Zhang T
Ther Adv Med Oncol; 2020; 12():1758835920940946. PubMed ID: 32728395
[TBL] [Abstract][Full Text] [Related]
4. Serum and glucocorticoid kinase 1 promoted the growth and migration of non-small cell lung cancer cells.
Xiaobo Y; Qiang L; Xiong Q; Zheng R; Jianhua Z; Zhifeng L; Yijiang S; Zheng J
Gene; 2016 Jan; 576(1 Pt 2):339-46. PubMed ID: 26548813
[TBL] [Abstract][Full Text] [Related]
5. Serum and glucocorticoid-regulated kinase 1 (SGK1) is a predictor of poor prognosis in non-small cell lung cancer, and its dynamic pattern following treatment with SGK1 inhibitor and γ-ray irradiation was elucidated.
Tang Z; Shen Q; Xie H; Zhou Z; Shi G; Zhang C; Mohammed A; Wu Y; Ni S; Zhou X
Oncol Rep; 2018 Mar; 39(3):1505-1515. PubMed ID: 29328462
[TBL] [Abstract][Full Text] [Related]
6. Determination of SGK1 mRNA in non-small cell lung cancer samples underlines high expression in squamous cell carcinomas.
Abbruzzese C; Mattarocci S; Pizzuti L; Mileo AM; Visca P; Antoniani B; Alessandrini G; Facciolo F; Amato R; D'Antona L; Rinaldi M; Felsani A; Perrotti N; Paggi MG
J Exp Clin Cancer Res; 2012 Jan; 31(1):4. PubMed ID: 22240294
[TBL] [Abstract][Full Text] [Related]
7. Regulation of ion channels by the serum- and glucocorticoid-inducible kinase SGK1.
Lang F; Shumilina E
FASEB J; 2013 Jan; 27(1):3-12. PubMed ID: 23012321
[TBL] [Abstract][Full Text] [Related]
8. Serum and Glucocorticoid Inducible Kinase 1-Sensitive Survival, Proliferation and Migration of Rhabdomyosarcoma Cells.
Schmid E; Stagno MJ; Yan J; Schleicher S; Yu W; Honisch S; Lang F; Fuchs J; Seitz G
Cell Physiol Biochem; 2017; 43(3):1301-1308. PubMed ID: 28992614
[TBL] [Abstract][Full Text] [Related]
9. Serum- and Glucocorticoid-Inducible Kinase 1 Confers Protection in Cell-Based and in In Vivo Neurotoxin Models via the c-Jun N-Terminal Kinase Signaling Pathway.
Iqbal S; Howard S; LoGrasso PV
Mol Cell Biol; 2015 Jun; 35(11):1992-2006. PubMed ID: 25825522
[TBL] [Abstract][Full Text] [Related]
10. The Enigmatic Role of Serum & Glucocorticoid Inducible Kinase 1 in the Endometrium.
Lang F; Rajaxavier J; Singh Y; Brucker SY; Salker MS
Front Cell Dev Biol; 2020; 8():556543. PubMed ID: 33195190
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential of serum and glucocorticoid inducible kinase inhibition.
Lang F; Voelkl J
Expert Opin Investig Drugs; 2013 Jun; 22(6):701-14. PubMed ID: 23506284
[TBL] [Abstract][Full Text] [Related]
12. Emerging Role of Serum Glucocorticoid-Regulated Kinase 1 in Pathological Pain.
Liu B; Li N; He Z; Zhang X; Duan G
Front Mol Neurosci; 2021; 14():683527. PubMed ID: 34093127
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II mediates cell survival through upregulation and activation of the serum and glucocorticoid inducible kinase 1.
Baskin R; Sayeski PP
Cell Signal; 2012 Feb; 24(2):435-442. PubMed ID: 21963429
[TBL] [Abstract][Full Text] [Related]
14. Serum/glucocorticoid-regulated kinase 1 expression in primary human prostate cancers.
Szmulewitz RZ; Chung E; Al-Ahmadie H; Daniel S; Kocherginsky M; Razmaria A; Zagaja GP; Brendler CB; Stadler WM; Conzen SD
Prostate; 2012 Feb; 72(2):157-64. PubMed ID: 21563193
[TBL] [Abstract][Full Text] [Related]
15. The Emerging Role of SGK1 (Serum- and Glucocorticoid-Regulated Kinase 1) in Major Depressive Disorder: Hypothesis and Mechanisms.
Dattilo V; Amato R; Perrotti N; Gennarelli M
Front Genet; 2020; 11():826. PubMed ID: 32849818
[TBL] [Abstract][Full Text] [Related]
16. The physiological impact of the serum and glucocorticoid-inducible kinase SGK1.
Lang F; Artunc F; Vallon V
Curr Opin Nephrol Hypertens; 2009 Sep; 18(5):439-48. PubMed ID: 19584721
[TBL] [Abstract][Full Text] [Related]
17. Morphine and cocaine increase serum- and glucocorticoid-inducible kinase 1 activity in the ventral tegmental area.
Heller EA; Kaska S; Fallon B; Ferguson D; Kennedy PJ; Neve RL; Nestler EJ; Mazei-Robison MS
J Neurochem; 2015 Jan; 132(2):243-53. PubMed ID: 25099208
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid receptor activity contributes to resistance to androgen-targeted therapy in prostate cancer.
Isikbay M; Otto K; Kregel S; Kach J; Cai Y; Vander Griend DJ; Conzen SD; Szmulewitz RZ
Horm Cancer; 2014 Apr; 5(2):72-89. PubMed ID: 24615402
[TBL] [Abstract][Full Text] [Related]
19. Serum- and glucocorticoid-inducible kinase 1 sensitive NF-κB signaling in dendritic cells.
Schmid E; Xuan NT; Zahir N; Russo A; Yang W; Kuhl D; Faggio C; Shumilina E; Lang F
Cell Physiol Biochem; 2014; 34(3):943-54. PubMed ID: 25200670
[TBL] [Abstract][Full Text] [Related]
20. SGK1 in Human Cancer: Emerging Roles and Mechanisms.
Sang Y; Kong P; Zhang S; Zhang L; Cao Y; Duan X; Sun T; Tao Z; Liu W
Front Oncol; 2020; 10():608722. PubMed ID: 33542904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
